Article Details

Be Biopharma Closes $130M Financing - FinSMEs

Retrieved on: 2022-04-18 19:56:22

Tags for this article:

Click the tags to see associated articles and topics

Be Biopharma Closes $130M Financing - FinSMEs. View article details on hiswai:

Excerpt

Be Biopharma, a Cambridge, MA-based developer of Engineered B Cell Medicines (BeCM), closed a $130m financing.

Article found on: www.finsmes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up